Blog

Amy C. Moore: LUNGevity Foundation International Lung Cancer Survivorship Conference

Photo taken from Amy C. Moore/LinkedIn

Jun 13, 2024, 10:46

Amy C. Moore: LUNGevity Foundation International Lung Cancer Survivorship Conference

Amy C. Moore, VP of Global Engagement and Patient Partnerships, LUNGevity Foundation, shared a post on LinkedIn:

“It has been 20 years since the discovery of the EGFR mutation ushered in the era of precision medicine for lung cancer. We are celebrating this important milestone and many more research advances at this year’s LUNGevity Foundation International Lung Cancer Survivorship Conference (ILCSC24), happening virtually Sept 20 – 21. Sign up to get notified when registration opens”

Read further.
Source: Amy C. Moore/LinkedIn

Amy C. Moore cancer EGFR-mutation ILCSC24 International Lung Cancer Survivorship Conference lung cancer research LUNGevity Foundation OncoDaily Oncology Precision Medicine registration notification research advances survivorship virtual conference

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC

Oncologist Near Me – Nazik Hammad: A Leader in Cancer Care, Medical Education, and Health Equity

Garo Armen - A Bold Call to Action: Embracing Real-Time Innovation in Pediatric Cancer

Black History Month 2025: Honoring Contributions to Oncology